On behalf of my coauthors, I thank Drs. Ba and Kong for their comments and agree that further type 2 diabetes (T2D)-specific information, such as duration of disease, would be of interest and highlighted the same in our discussion.1This is the limitation of repurposing a dataset that was developed to answer different questions. We included what T2D-specific data were available within the Alzheimer's Disease Neuroimaging Initiative (ADNI) and respectfully point out that we reported data regarding fasting glucose, diabetes medication use, blood pressure, and measures of obesity (see table 1).1
from Neurology recent issues https://ift.tt/2Q87hiC
Comments
Post a Comment